| 000 | 01391 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516005215.0 | ||
| 264 | 0 | _c20111212 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1476-5365 | ||
| 024 | 7 |
_a10.1038/bmt.2010.239 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuillen, K | |
| 245 | 0 | 0 |
_aA second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cJul 2011 |
||
| 300 |
_a976-80 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmyloidosis _xdrug therapy |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Mobilization _xmethods |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoglobulin Light-chain Amyloidosis |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelphalan _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aSeldin, D C | |
| 700 | 1 | _aFinn, K T | |
| 700 | 1 | _aSanchorawala, V | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 46 _gno. 7 _gp. 976-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bmt.2010.239 _zAvailable from publisher's website |
| 999 |
_c20259875 _d20259875 |
||